| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
16,604 |
3,878 |
$1.37M |
| 97161 |
|
1,733 |
1,217 |
$189K |
| 97162 |
|
965 |
694 |
$103K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
561 |
529 |
$30K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
839 |
736 |
$26K |
| 84443 |
Thyroid stimulating hormone (TSH) |
4,863 |
4,406 |
$26K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
816 |
693 |
$24K |
| 80053 |
Comprehensive metabolic panel |
8,125 |
7,112 |
$18K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,402 |
1,265 |
$17K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,403 |
1,266 |
$17K |
| 87081 |
|
4,082 |
3,588 |
$11K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,393 |
2,940 |
$11K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
204 |
77 |
$9K |
| 73630 |
|
609 |
554 |
$7K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,505 |
7,293 |
$6K |
| 71046 |
Radiologic examination, chest; 2 views |
601 |
556 |
$5K |
| 73562 |
|
415 |
387 |
$5K |
| 87186 |
|
1,087 |
976 |
$4K |
| 97165 |
|
315 |
170 |
$3K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,326 |
1,136 |
$3K |
| 80061 |
Lipid panel |
4,671 |
4,240 |
$3K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
102 |
25 |
$3K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
278 |
169 |
$3K |
| 74018 |
|
291 |
264 |
$3K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,916 |
1,738 |
$3K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
368 |
347 |
$3K |
| 73610 |
|
163 |
148 |
$3K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,438 |
2,203 |
$2K |
| 87088 |
|
661 |
602 |
$2K |
| 85610 |
|
1,536 |
874 |
$2K |
| 82607 |
|
660 |
642 |
$2K |
| 73030 |
|
131 |
125 |
$2K |
| 86803 |
|
469 |
408 |
$2K |
| 83970 |
|
118 |
112 |
$1K |
| 86038 |
|
345 |
317 |
$1K |
| 73110 |
|
107 |
92 |
$1K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
453 |
426 |
$1K |
| 86780 |
|
618 |
531 |
$1K |
| 72110 |
|
72 |
71 |
$1K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
163 |
150 |
$1K |
| 82728 |
|
933 |
833 |
$968.51 |
| 84466 |
|
672 |
613 |
$904.35 |
| 87210 |
|
993 |
869 |
$869.65 |
| 84403 |
|
81 |
71 |
$817.76 |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
71 |
62 |
$801.69 |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
37 |
36 |
$773.60 |
| 84439 |
|
916 |
808 |
$726.72 |
| 87522 |
Neg quan hep c or qual rna |
29 |
27 |
$683.78 |
| 87070 |
|
449 |
382 |
$630.63 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
89 |
42 |
$576.23 |
| 82570 |
|
967 |
855 |
$536.84 |
| 83735 |
|
627 |
526 |
$418.41 |
| 86140 |
|
598 |
451 |
$415.93 |
| 87147 |
|
904 |
807 |
$388.95 |
| 81001 |
|
787 |
626 |
$354.19 |
| 80069 |
|
193 |
182 |
$349.45 |
| 88304 |
|
12 |
12 |
$330.56 |
| 83540 |
|
678 |
621 |
$320.17 |
| 85652 |
|
1,071 |
874 |
$315.56 |
| 87340 |
|
386 |
318 |
$309.23 |
| 73130 |
|
34 |
31 |
$291.85 |
| 84702 |
|
146 |
123 |
$273.45 |
| 82043 |
|
799 |
712 |
$261.19 |
| 73502 |
|
14 |
14 |
$220.52 |
| 82784 |
|
26 |
25 |
$210.45 |
| 81015 |
|
402 |
369 |
$199.04 |
| 83690 |
|
273 |
241 |
$190.09 |
| 92567 |
|
12 |
12 |
$178.64 |
| 80076 |
|
67 |
65 |
$167.47 |
| 81003 |
|
463 |
383 |
$141.54 |
| 86850 |
|
268 |
190 |
$137.80 |
| 87899 |
|
12 |
12 |
$115.55 |
| 82746 |
|
70 |
67 |
$95.21 |
| 80074 |
|
12 |
12 |
$94.34 |
| 86901 |
|
307 |
230 |
$91.65 |
| 73140 |
|
12 |
12 |
$84.39 |
| 84550 |
|
156 |
131 |
$83.98 |
| G0145 |
Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision |
30 |
29 |
$74.25 |
| 86430 |
|
133 |
128 |
$63.55 |
| 81025 |
|
124 |
110 |
$60.81 |
| 85027 |
|
112 |
99 |
$53.36 |
| 86900 |
|
177 |
135 |
$42.56 |
| 82150 |
|
40 |
39 |
$34.47 |
| 86706 |
|
14 |
12 |
$34.20 |
| 87045 |
|
12 |
12 |
$29.90 |
| 84156 |
|
101 |
83 |
$21.36 |
| 84100 |
|
28 |
26 |
$15.99 |
| 82465 |
|
13 |
13 |
$6.20 |
| 82550 |
|
13 |
13 |
$5.92 |
| 87046 |
|
12 |
12 |
$4.68 |